TickerFacts.

A business in context

NBIX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-25 · 0000914475-26-000045 · Items 5.02

  2. 4 · Ownership change

    Report date 2026-09-11 · 0001965808-26-000015

  3. 4 · Ownership change

    Report date 2026-09-11 · 0001909817-26-000010

  4. 4 · Ownership change

    Report date 2026-09-11 · 0001894425-26-000020

  5. 4 · Ownership change

    Report date 2026-09-11 · 0001818524-26-000006

  6. 4 · Ownership change

    Report date 2026-09-11 · 0001776977-26-000013

  7. 4 · Ownership change

    Report date 2026-09-11 · 0001724097-26-000010

  8. 4 · Ownership change

    Report date 2026-09-11 · 0001643653-26-000018

  9. 4 · Ownership change

    Report date 2026-09-11 · 0001567160-26-000009

  10. 8-K/A · Current report

    Report date 2026-05-14 · 0001193125-26-328470 · Items 9.01

  11. 10-Q · Quarterly report

    Report date 2026-06-30 · 0000914475-26-000037

  12. 8-K · Current report

    Report date 2026-07-30 · 0000914475-26-000035 · Items 2.02,9.01

  13. 8-K · Current report

    Report date 2026-05-27 · 0000914475-26-000029 · Items 5.02,5.07

  14. 8-K · Current report

    Report date 2026-05-14 · 0001193125-26-228013 · Items 1.01,2.01,2.03,7.01,9.01

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0000914475-26-000026

  16. 8-K · Current report

    Report date 2026-05-05 · 0000914475-26-000025 · Items 2.02,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-04-15 · 0000914475-26-000015

  18. 8-K · Current report

    Report date 2026-04-05 · 0001193125-26-142904 · Items 1.01,9.01

  19. 10-K · Annual report

    Report date 2025-12-31 · 0000914475-26-000007

  20. 8-K · Current report

    Report date 2026-02-11 · 0000914475-26-000006 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2025-11-21 · 0000914475-25-000186 · Items 5.02,9.01

  22. 10-Q · Quarterly report

    Report date 2025-09-30 · 0000914475-25-000181

  23. 8-K · Current report

    Report date 2025-10-28 · 0000914475-25-000180 · Items 2.02,9.01

  24. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000914475-25-000158

  25. 8-K · Current report

    Report date 2025-07-30 · 0000914475-25-000157 · Items 2.02,9.01

  26. 8-K · Current report

    Report date 2025-05-30 · 0000914475-25-000139 · Items 5.02,9.01

  27. 8-K · Current report

    Report date 2025-05-21 · 0000914475-25-000120 · Items 5.02,5.07

  28. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000914475-25-000100

  29. 8-K · Current report

    Report date 2025-05-05 · 0000914475-25-000099 · Items 2.02,9.01

  30. DEF 14A · Proxy statement

    Report date 2025-04-09 · 0000914475-25-000091

  31. 8-K · Current report

    Report date 2025-04-02 · 0000914475-25-000081 · Items 5.02,7.01,9.01

  32. 10-K · Annual report

    Report date 2024-12-31 · 0000914475-25-000037

  33. 8-K · Current report

    Report date 2025-02-06 · 0000914475-25-000034 · Items 2.02,9.01

  34. 8-K · Current report

    Report date 2025-01-24 · 0000914475-25-000006 · Items 1.01,7.01,9.01

  35. 8-K · Current report

    Report date 2024-12-20 · 0000914475-24-000229 · Items 8.01

  36. 8-K · Current report

    Report date 2024-10-31 · 0000914475-24-000214 · Items 8.01

  37. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000914475-24-000211

  38. 8-K · Current report

    Report date 2024-10-30 · 0000914475-24-000210 · Items 2.02,9.01

  39. SC 13G · Ownership disclosure

    0000093751-24-000783

  40. 8-K · Current report

    Report date 2024-10-11 · 0000914475-24-000206 · Items 5.02

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 9 transaction rows9SGrant / award: 11 transaction rows11AExercise / conversion: 14 transaction rows14MTax / exercise payment: 11 transaction rows11FGift: 2 transaction rows2G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

47 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-14
2026-09-15
Boyer David W.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock826.0157.45
2026-09-14
2026-09-15
ABERNETHY MATT
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2311.0157.2
2026-09-11
2026-09-15
Delaet IngridA · Grant / award
Acquired
Common Stock4483.00.0
2026-09-11
2026-09-15
Delaet IngridF · Tax / exercise payment
Disposed
Common Stock2419.0156.22
2026-09-11
2026-09-15
Boyer David W.
10b5-1 checkbox reported
F · Tax / exercise payment
Disposed
Common Stock1936.0156.22
2026-09-11
2026-09-15
Boyer David W.
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock3587.00.0
2026-09-11
2026-09-15
Onyia JudeA · Grant / award
Acquired
Common Stock3587.00.0
2026-09-11
2026-09-15
Onyia JudeF · Tax / exercise payment
Disposed
Common Stock1936.0156.22
2026-09-11
2026-09-15
Keswani Sanjay ChandruF · Tax / exercise payment
Disposed
Common Stock2112.0156.22
2026-09-11
2026-09-15
Keswani Sanjay ChandruA · Grant / award
Acquired
Common Stock3914.00.0
2026-09-11
2026-09-15
Cooke JulieA · Grant / award
Acquired
Common Stock3587.00.0
2026-09-11
2026-09-15
Cooke JulieF · Tax / exercise payment
Disposed
Common Stock1936.0156.22
2026-09-11
2026-09-15
ABERNETHY MATT
10b5-1 checkbox reported
F · Tax / exercise payment
Disposed
Common Stock2709.0156.22
2026-09-11
2026-09-15
ABERNETHY MATT
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock5020.00.0
2026-09-11
2026-09-15
BENEVICH ERICA · Grant / award
Acquired
Common Stock6275.00.0
2026-09-11
2026-09-15
BENEVICH ERICF · Tax / exercise payment
Disposed
Common Stock3386.0156.22
2026-09-11
2026-09-15
Gano KyleA · Grant / award
Acquired
Common Stock6275.00.0
2026-09-11
2026-09-15
Gano KyleA · Grant / award
Acquired
Common Stock1842.00.0
2026-09-11
2026-09-15
Gano KyleF · Tax / exercise payment
Disposed
Common Stock994.0156.22
2026-09-11
2026-09-15
Gano KyleF · Tax / exercise payment
Disposed
Common Stock3386.0156.22
2026-09-11
2026-09-15
Lippoldt DarinF · Tax / exercise payment
Disposed
Common Stock2419.0156.22
2026-09-11
2026-09-15
Lippoldt DarinA · Grant / award
Acquired
Common Stock4483.00.0
2026-09-11
2026-09-15
GORMAN KEVIN CHARLESA · Grant / award
Acquired
Common Stock14343.00.0
2026-09-11
2026-09-15
GORMAN KEVIN CHARLESF · Tax / exercise payment
Disposed
Common Stock7839.0156.22
2026-09-09
2026-09-10
BENEVICH ERIC
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock3194.043.24
2026-09-09
2026-09-10
BENEVICH ERIC
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2154.0154.61
2026-09-09
2026-09-10
BENEVICH ERIC
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Incentive Stock Option
Derivative security
3194.00.0
2026-09-02
2026-09-03
SHERWIN STEPHEN AG · Gift
Disposed
Common Stock1000.00.0
2026-08-04
2026-08-05
Onyia JudeG · Gift
Disposed
Common Stock2409.00.0
2026-07-29
2026-07-30
Norwalk Leslie V
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock842.0139.43
2026-07-29
2026-07-30
Norwalk Leslie V
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option
Derivative security
842.00.0
2026-07-28
2026-07-30
Norwalk Leslie V
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1250.0182.01
2026-07-10
2026-07-13
Delaet Ingrid
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock4367.0106.02
2026-07-10
2026-07-13
Delaet Ingrid
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock4367.0181.02
2026-07-10
2026-07-13
Delaet Ingrid
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option
Derivative security
4367.00.0
2026-07-09
2026-07-09
Delaet Ingrid
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock8433.0103.52
2026-07-09
2026-07-09
Delaet Ingrid
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock8433.0178.72
2026-07-09
2026-07-09
Delaet Ingrid
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option
Derivative security
8433.00.0
2026-07-09
2026-07-13
Lippoldt Darin
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock10000.081.49
2026-07-09
2026-07-13
Lippoldt Darin
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock10000.0179.6
2026-07-09
2026-07-13
Lippoldt Darin
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option
Derivative security
10000.00.0
2026-07-08
2026-07-09
Delaet Ingrid
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2737.0178.54
2026-07-08
2026-07-09
Delaet Ingrid
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock2737.0103.52
2026-07-08
2026-07-09
Delaet Ingrid
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option
Derivative security
2737.00.0
2026-07-07
2026-07-09
Delaet Ingrid
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock3401.0103.52
2026-07-07
2026-07-09
Delaet Ingrid
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3401.0178.57
2026-07-07
2026-07-09
Delaet Ingrid
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option
Derivative security
3401.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000914475NEUROCRINE BIOSCIENCES INC

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300FECER0XBN49756
GLEIF legal name
Neurocrine Biosciences, Inc.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2026-07-29T18:14:48Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Neurocrine Biosciences · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$2.36B$2.53B
2023-12-31$1.89B$2.09B
2022-12-31$1.49B$1.71B
2021-12-31$1.13B$1.41B
2020-12-31$1.05B$1.36B
2019-12-31$788.10M$1.04B
2018-12-31$451.20M$605.40M
2017-12-31$161.63M$222.17M

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗